A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II) (STRIDE II)
STRIDE II: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System II
Sponsor: Penumbra Inc.
This observational or N/A phase trial investigates LE ALI and Lower Extremity Acute Limb Ischemia and is currently actively recruiting participants. Penumbra Inc. leads this study, which shows 8 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Apr 28, 2026 — Present [daily]
Recruiting
-
Mar 2026 — Apr 2026 [monthly]
Recruiting
-
Feb 2026 — Mar 2026 [monthly]
Recruiting
-
Jan 2026 — Feb 2026 [monthly]
Recruiting
-
Dec 2025 — Jan 2026 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Aug 2025 — Dec 2025 [monthly]
Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2025 — Jul 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
Contact Information
- Penumbra Inc.
For direct contact, visit the study record on ClinicalTrials.gov .